Navigation Links
Shop 'n Save Pharmacy Helps Vitalize Members of Wellness-based Health Insurance Plan
Date:9/25/2007

ST. LOUIS, Sept. 25 /PRNewswire/ -- Shop 'n Save Pharmacy, a leading network of pharmacies providing patient care services in the St. Louis area, has entered into an agreement with Destiny Health, a Chicago-based provider of wellness-based health insurance, to provide a wellness service, Vitality Check(TM), to members of The Destiny Health Empowerment Plan(TM).

Fully integrated with the insurance portion of The Destiny Health Empowerment Plan, Vitality is a wellness program that encourages members with tangible rewards. Members can redeem their Vitality Bucks for Vitality Rewards(R) that include airline miles, vacation packages, name brand merchandise, iTunes and more.

A Vitality Check is a health assessment that members are encouraged to partake in to learn more about their current health conditions. For example, during a Vitality Check, Shop 'n Save pharmacists will test member's blood glucose, blood pressure and cholesterol levels, as well as obtain height and weight measurements to calculate Body Mass Index (BMI). These results will be sent directly to Destiny Health, and members will be awarded Vitality Bucks(TM) for participating in the Vitality Check and for the test results as well, depending on the outcome. The closer they are to being in the healthy range, the more Vitality Bucks received.

Destiny Health members will only pay $40 for a Vitality Check at participating Shop 'n Save pharmacy locations. Members will have their blood tested and their results will be mailed to them within 7-10 business days. The pharmacist will follow-up with the member to discuss the results and provide appropriate recommendations.

"Shop 'n Save is happy to be a part of Destiny Health's dedication to their members' health," says Chris Dimos, President, pharmacy operations for SUPERVALU. "As a network of pharmacies, many people think we only provide for our customers who are in need of care when they're sick, but in fact, like Destiny Health, we ar
'/>"/>

SOURCE Destiny Health
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. A success for the Indian pharmacy: gets licence to manufacture Tamiflu
2. Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies
3. Pharmacy Board Says Pharmacists Have Right To Refuse Morning-After Pill
4. Pharmacy Care Program Can Increase Medication Adherence in Elderly
5. Karnataka Pharmacy Gets Licence to Produce Medicines from White Arecanut
6. California Pharmacy Chain Provides Services to Hispanic Community
7. Antibiotics Helps Autism
8. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
9. Sperm washing helps couples – Breakthrough in focu
10. Patient’s perception of health status helps in better recover
11. New vaccine helps allergy and asthma patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...s that a child’s race may be a factor in determini...ated with environmental tobacco smoke (ETS). //The... asthma, who are exposed to ETS, have significantl... their Caucasian counterparts. “African American ...
...o experience a change in health caused by an unint...thout insurance are more likely to have difficulty...ely to experience larger declines in short-term he...ey, Ph.D., of the Urban Institute, Washington, D.C...
...ean of University of Massachusetts Medical School ...ealth reasons//. It was reported that he has devel...le for the merger of state hospital and the privat...up the $ 100 million research lab there. In 1982, ...
...kesh Haikerwal, said today the Government must ame...able// elderly Australians from abuse in aged care...ecurity and Protection) Bill 2007, which the Gover... calls for the compulsory reporting of any physica...
Other Medicine News:Health News:Race Affects Tobacco Absorption in Children 2Health News:Uninsured Often Receive Less Medical Care 2Health News:AMA Urges Government To Amend Aged Care Legislation 2
(Date:8/14/2008)...all/ -- Pharmasset, Inc.,(Nasdaq: VRUS ), a clini...overing, developing and commercializing novel drug...nancial results for the third fiscal,quarter ended...ributable to,common stockholders of $15.0 million,...d June 30, 2008, as compared to a net loss attribu...
(Date:8/14/2008)...nable Targeting and Increase Spee.... and HEIDELBERG, Germany, Aug. 14 /-...titute (TGen) today announced,the formation of a c...ration-Sequencing equipment in conjunction with fe..., febit,s HybSelect(TM) Technology enables select...
(Date:8/13/2008)...As biotechnology,pharmaceutical and medical devic...nd their own borders to other parts of the world, ...mplicated regulatory environments,challenge those ...lysis by,Aon Corporation (NYSE: AOC ). Aon,s 2008... a visual representation of the complex insurance,...
(Date:8/13/2008)... to automatically measure QT inter...lif., Aug. 13 /- NewCardio,...stic and services company, today,revealed the resu...no(TM),(the "NCE3 Study"). The study was led by an...t with extensive experience in pharmaceutical clin...
Breaking Medicine Technology:Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4NewCardio Announces Positive Results From Third Clinical Validation Study 2NewCardio Announces Positive Results From Third Clinical Validation Study 3NewCardio Announces Positive Results From Third Clinical Validation Study 4NewCardio Announces Positive Results From Third Clinical Validation Study 5Molecular alliance that sustains embryonic stem cell state 13467 1Molecular alliance that sustains embryonic stem cell state 13467 2Molecular alliance that sustains embryonic stem cell state 13467 3Non Polyp Colon Lesions Hard to Detect 13462 1Non Polyp Colon Lesions Hard to Detect 13462 2Non Polyp Colon Lesions Hard to Detect 13462 3Sticky blood protein yields clues to autism 13458 1Sticky blood protein yields clues to autism 13458 2Sticky blood protein yields clues to autism 13458 3Specialists in drug discovery and development convene 13455 1Specialists in drug discovery and development convene 13455 2
...t Study in American Heart Journal , ,WINNIPEG, Ma...mex:MCU), a cardiovascular focused, biopharmaceuti...llow-up results from the,STRATEGY (Single High-Dos...us Abciximab and Bare Metal Stent In Acute Myocard...dition of the Journal,of the American College of C...
...1, 2007 /PRNewswire/ -- Phase 3 results,from the R...an,etexilate once daily, administered for an avera...o administered for an average of 33,days, in preve...ortality after total hip replacement surgery. In t...ith dabigatran etexilate was,similar to enoxaparin...
Other Medicine Technology:Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5
...e) injection was introduced in 1988, it ushered in...gnetic resonance imaging (MRI). It became the worl...e product is still a market leader with indication...n over 85 countries and has established a positive...
Up to 20% of the 17 million echocardiograms performed annually in the U.S. are suboptimal. Activated DEFINITY increases the power of echocardiography, obtaining clearer images of the heart than with
...neration ultrasound medical diagnostic product wit...ders of the heart. This allows doctors to see abno...asound scanning procedure, enabling more accurate ...viding guidance for the selection and monitoring o...
...isosmolar contrast medium (IOCM™) available ...ood, VISIPAQUE was designed for patient safety and...um formulated with sodium and calcium in a ratio e...A approval for use in children over one year of ag...
Medicine Products: